Clinical Trial Update: Palopegteriparatide in Chronic Hypoparathyroidism

View source ↗

Summary

This clinical trial update notes that the study evaluating Palopegteriparatide for chronic hypoparathyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• Palopegteriparatide (palopegteriparatide)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Hypoparathyroidism | Status: COMPLETED